SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-23-030510
Filing Date
2023-06-20
Accepted
2023-06-20 16:55:01
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFM14A ny20009217x2_defm14a.htm DEFM14A 1938525
2 logo_cyclerion-c.jpg GRAPHIC 43166
3 logo_stifel.jpg GRAPHIC 30645
4 ny20009217x1_pc03.jpg GRAPHIC 57137
5 ny20009217x2_pc01.jpg GRAPHIC 810218
6 ny20009217x2_pc02.jpg GRAPHIC 678557
7 sig_stifelnicolaus2.jpg GRAPHIC 38729
  Complete submission text file 0001140361-23-030510.txt   4222172
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38787 | Film No.: 231025993
SIC: 2834 Pharmaceutical Preparations